Phase I pharmacokinetic study of the novel antitumor agent SR233377.
LoRusso PM, Foster BJ, Wozniak A, Heilbrun LK, McCormick JI, Ruble PE, Graham MA, Purvis J, Rake J, Drozd M, Lockwood GF, Corbett TH.
LoRusso PM, et al. Among authors: ruble pe.
Clin Cancer Res. 2000 Aug;6(8):3088-94.
Clin Cancer Res. 2000.
PMID: 10955788
Clinical Trial.